RMD
ResMed Inc. Healthcare - Medical Instruments & Supplies Investor Relations →
ResMed Inc. (RMD) closed at $225.99 as of 2026-03-20, trading 4.0% above its 200-week moving average of $217.31. The stock is currently moving closer to the line, down from 6.3% last week. The 14-week RSI sits at 38, indicating neutral momentum.
Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.00 ratio) is neutral — neither side is clearly dominating.
Over the past 1559 weeks of data, RMD has crossed below its 200-week moving average 12 times. On average, these episodes lasted 12 weeks. Historically, investors who bought RMD at the start of these episodes saw an average one-year return of +32.2%.
With a market cap of $33.0 billion, RMD is a large-cap stock. The company generates a free cash flow yield of 4.3%. Return on equity stands at 25.7%, indicating strong profitability. The stock trades at 5.2x book value.
RMD passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 29.9 years, a hypothetical investment of $100 in RMD would have grown to $25282, compared to $1630 for the S&P 500. That represents an annualized return of 20.3% vs 9.8% for the index — confirming RMD as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 103.8% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: RMD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After RMD Crosses Below the Line?
Across 12 historical episodes, buying RMD when it crossed below its 200-week moving average produced an average return of +31.7% after 12 months (median +35.0%), compared to +14.2% for the S&P 500 over the same periods. 100% of those episodes were profitable after one year. After 24 months, the average return was +74.4% vs +36.2% for the index.
Each line shows $100 invested at the moment RMD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
RMD has crossed below its 200-week MA 12 times with an average 1-year return of +32.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1996 | May 1996 | 1 | 0.9% | +55.6% | +32205.1% |
| May 2002 | Aug 2002 | 14 | 21.4% | +25.3% | +3623.7% |
| Aug 2002 | Oct 2002 | 9 | 15.5% | +39.2% | +3404.6% |
| Nov 2002 | Apr 2003 | 21 | 13.5% | +20.3% | +3264.1% |
| Jun 2008 | Aug 2008 | 8 | 11.4% | +4.8% | +1324.1% |
| Oct 2008 | Feb 2009 | 17 | 23.1% | +34.9% | +1508.1% |
| Feb 2009 | Aug 2009 | 24 | 22.7% | +40.7% | +1234.5% |
| Nov 2011 | Jan 2012 | 8 | 4.3% | +63.5% | +990.7% |
| Jul 2023 | Apr 2024 | 38 | 34.8% | +26.1% | +29.4% |
| May 2024 | Jun 2024 | 1 | 1.0% | +19.7% | +11.3% |
| Jun 2024 | Jul 2024 | 6 | 8.4% | +24.4% | +11.5% |
| Mar 2025 | Apr 2025 | 3 | 4.9% | N/A | +11.1% |
| Average | 12 | — | +32.2% | — |
Frequently Asked Questions
Is RMD below its 200-week moving average?
No. ResMed Inc. (RMD) is currently 4.0% above its 200-week moving average of $217.31. It would need to fall to $217.31 to cross below the line.
What is RMD's 200-week moving average price?
ResMed Inc.'s 200-week moving average is $217.31 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when RMD drops below its 200-week moving average?
RMD has crossed below its 200-week moving average 12 times in our data. On average, buying at that moment produced a one-year return of +32.2%. These dips have historically been decent entry points. These episodes lasted 12 weeks on average.
Is RMD a good value right now?
Here's what our data says about RMD as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 38. Free cash flow yield is 4.3%. Return on equity is 25.7%. Price-to-book is 5.2x. This is not a buy or sell recommendation — always do your own research.
How does RMD compare to the S&P 500?
Over the past 29.9 years, $100 invested in RMD would have grown to $25282, compared to $1630 for the S&P 500. That's 20.3% annualized vs 9.8% for the index. RMD has outperformed the broader market over this period.
Does RMD pay a dividend?
Yes. ResMed Inc. currently pays a dividend yield of 106.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20